Associate Professor of Biostatistics & Medicine at Mayo Clinic
Rochester, MN
Joined December 2013
- Tweets22
- Following844
- Followers2.3K
- Likes3.1K
Matthew J. Maurer, ScD retweeted
2nd annual heme statistician meetup at #ASH25 (group photo coming soon)! Thanks to @MaurerStats for organizing! I continue to be impressed with @ASH_hematology’s support of biostatisticians! Be sure to check out the Stat Spotlight Session on Monday at 10:30am!!
We will be presenting details on our FLP-R prognostic model and trial enrichment tool for R/R follicular #lymphoma at the Monday poster session of #ASH25. The model calculator is available at rtools.mayo.edu/flp_r_calcul…
#lymsm
#lymsm
Matthew J. Maurer, ScD retweeted
Now for #LeonardList 2 in countdown of #ASH2025 #ASH25 top #lymphoma abstracts - Seheult et al abst 117: Lymphovision: A lymphoma-specialized foundation model for histology-based lymphoma
classification and subtyping meetings-api.hematology.org/…
Matthew J. Maurer, ScD retweeted
#LeonardList 2 in countdown of #ASH2025 #ASH25 top #lymphoma abstracts - Seheult et al abst 117: Lymphovision...A neural network being trained to identify lymphoma/non-lymphoma, lymphoma type/subtype & potentially even mutation profiling and prognosis meetings-api.hematology.org/…
Now for #LeonardList 2 in countdown of #ASH2025 #ASH25 top #lymphoma abstracts - Seheult et al abst 117: Lymphovision: A lymphoma-specialized foundation model for histology-based lymphoma
classification and subtyping meetings-api.hematology.org/…
Matthew J. Maurer, ScD retweeted
Best clinical FL POD24 predicttion tool on-line! bit.ly/3KCEXUw 🎄Proud to be 2nd author.
👏Heroic and practice changing work led by @MaurerStats and James Cerhan. Strong data (a lot pts from 🇨🇿), kudos to @MarekTrnenyDr
🧮 easily ➡️ bit.ly/3Y1YkJJ
Matthew J. Maurer, ScD retweeted
Our FLIPI24: Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma. Thanks to @MaurerStats and entire LEO team for this collaboration. @JCO_ASCO
ascopubs.org/doi/full/10.120…
Our manuscript on the FLIPI24 prognostic model and clinical trial enrichment tool for newly diagnosed #follicular lymphoma is now online @JCO_ASCO :
ascopubs.org/doi/10.1200/JCO…
Link to online calculator: rtools.mayo.edu/flipi24_calc…
#lymsm
Matthew J. Maurer, ScD retweeted
𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝!
Original Article: “An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma” by A.M. Rodday (@AngieRodday) et al. eviden.cc/43ZUl2O
@DrAEvens @TuftsMedicalCtr @TuftsMCResearch @RutgersCancer @RWJBarnabas @icmlugano #18ICML
ALT Panel A shows Kaplan–Meier curves of 2-year progression-free survival (PFS) stratified by sex for the development cohort. Plots of penalized smoothing splines based on partial residuals showing the relationships between 2-year PFS and continuous values are shown for maximum tumor diameter, in Panel B; hemoglobin, in Panel C; and albumin, in Panel D, for the development cohort.
Matthew J. Maurer, ScD retweeted
Dr @GregNowakowski gives nice overview of the >30-year-old IPI, international prognostic index, in DLBCL, + various more recent attempts to prognosticate in DLBCL
@MaurerStats's analysis of outcomes by days to treatment initiation particularly interesting
#EHA2025 #lymsm
Matthew J. Maurer, ScD retweeted
Our review is just out in @BloodJournal
Endpoints and outcomes in follicular lymphoma ashpublications.org/blood/ar…
Great collaboration with @ChrisRFlowersMD @MaurerStats
@fredhutch @uwmnewsroom
